Rimas V. Lukas

IDO1 Inhibition Synergizes with Radiation and PD-1 Blockade to Durably Increase Survival Against Advanced Glioblastoma

Erik Ladomersky, Lijie Zhai, Alicia Lenzen et al. · Clinical Cancer Research · 2018 · 202 citations · Full text

Repeated blood–brain barrier opening with an implantable ultrasound device for delivery of albumin-bound paclitaxel in patients with recurrent glioblastoma: a phase 1 trial

Adam M. Sonabend, Andrew Gould, Christina Amidei et al. · The Lancet Oncology · 2023 · 193 citations · Full text

Nanomedicine, Neuro-oncology, Focused Ultrasound +14

Neural stem cell delivery of an oncolytic adenovirus in newly diagnosed malignant glioma: a first-in-human, phase 1, dose-escalation trial

Jawad Fares, Atique U. Ahmed, Ilya V. Ulasov et al. · The Lancet Oncology · 2021 · 191 citations · Full text

Neuro-oncology, Glioma, Neural Stem Cell +8

ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma

Víctor A. Arrieta, Andrew Chen, J. Robert Kane et al. · Nature Cancer · 2021 · 111 citations · Full text

Neuro-oncology, Glioma, Erk1/2 Phosphorylation +8

Combined immunotherapy with controlled interleukin-12 gene therapy and immune checkpoint blockade in recurrent glioblastoma: An open-label, multi-institutional phase I trial

E. Antonio Chiocca, Arnold B. Gelb, Clark C. Chen et al. · Neuro-Oncology · 2021 · 101 citations · Full text